Evidence map›Paper›PMID 39072392›Full record

Trial reportFuture oncology (London, England)2024

Health-related quality of life in patients with Waldenström macroglobulinemia: results from the ASPEN trial.

Alessandra Tedeschi, Constantine S Tam, Roger G Owen, Christian Buske, Véronique Leblond, Meletios Dimopoulos, Ramón Garcia-Sanz, Jorge J Castillo, Judith Trotman, Steven P Treon and 8 more

Abstract readRandomized Controlled TrialClinical Trial, Phase IIIMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Alessandra TedeschiASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Constantine S TamAlfred Health & Monash University, Melbourne, Victoria, Australia.
Roger G OwenSt. James University Hospital, Leeds, UK.
Christian BuskeInstitute of Experimental Cancer Research, CCCU, University Hospital Ulm, Baden-Württemberg, Germany.
Véronique LeblondSorbonne University, Pitié Salpêtrière Hospital, Paris, France.
Meletios DimopoulosDepartment of Clinical Therapeutics, National & Kapodistrian University of Athens, Athens, Greece.
Ramón Garcia-SanzHospital Universitario de Salamanca, CIBERONC, Universidad de Salamanca, IBSAL, Salamanca, Spain.ORCID 0000-0003-4120-2787
Jorge J CastilloBing Center for Waldenström Macroglobiulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-9490-7532
Judith TrotmanConcord Repatriation General Hospital & University of Sydney, New South Wales, Australia.
Steven P TreonBing Center for Waldenström Macroglobiulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Keri YangBeiGene USA, Inc., San Mateo, CA, USA.
Boxiong TangBeiGene USA, Inc., San Mateo, CA, USA.
Heather AlleweltBeiGene USA, Inc., San Mateo, CA, USA.
Sheel PatelBeiGene USA, Inc., San Mateo, CA, USA.
Wai Y ChanBeiGene USA, Inc., San Mateo, CA, USA.
Aileen CohenBeiGene USA, Inc., San Mateo, CA, USA.
Shengnan ChenBeiGene (Shanghai) Co., Ltd, Shanghai,China.
Gisoo BarnesBeiGene USA, Inc., San Mateo, CA, USA.ORCID 0000-0001-5702-2903

Funding

BeiGene
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdeninePiperidinesPyrazolesPyrimidinesQuality of LifeWaldenstrom MacroglobulinemiaAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedMutationMyeloid Differentiation Factor 88Patient Reported Outcome MeasuresAdenineibrutinibMYD88 protein, humanMyeloid Differentiation Factor 88PiperidinesPyrazolesPyrimidineszanubrutinibASPEN trialBruton tyrosine kinase inhibitorhealth-related quality of lifeibrutinibpatient-reported outcomesWaldenström macroglobulinemiazanubrutinib

Identifiers

PMID39072392
PMCPMC11485878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.